![AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway | Cell Death & Disease AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-020-03030-7/MediaObjects/41419_2020_3030_Fig1_HTML.png)
AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway | Cell Death & Disease
The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis | PLOS ONE
![IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma](https://pub.mdpi-res.com/ijms/ijms-22-10271/article_deploy/html/images/ijms-22-10271-g001.png?1632469653)
IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
![Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study - eClinicalMedicine Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study - eClinicalMedicine](https://www.thelancet.com/cms/asset/4b046693-99b6-4208-bef2-be481d75610a/gr1.jpg)
Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study - eClinicalMedicine
![Orbiton Biomedical Pvt. Ltd. on Twitter: "Tumor Markers for Cancer Treatment #tumormarkers #biochemistry #medicallaboratory #orbitonbiomedical #MedicalDevices https://t.co/t8CaulFLks" / Twitter Orbiton Biomedical Pvt. Ltd. on Twitter: "Tumor Markers for Cancer Treatment #tumormarkers #biochemistry #medicallaboratory #orbitonbiomedical #MedicalDevices https://t.co/t8CaulFLks" / Twitter](https://pbs.twimg.com/media/E8UOSqwVEAEpE88.jpg)
Orbiton Biomedical Pvt. Ltd. on Twitter: "Tumor Markers for Cancer Treatment #tumormarkers #biochemistry #medicallaboratory #orbitonbiomedical #MedicalDevices https://t.co/t8CaulFLks" / Twitter
![α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study | British Journal of Cancer α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01363-4/MediaObjects/41416_2021_1363_Fig1_HTML.png)
α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study | British Journal of Cancer
![The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma | Scientific Reports The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-017-12834-1/MediaObjects/41598_2017_12834_Fig1_HTML.jpg)